Valeant Pharmaceuticals To Participate At The UBS Global Healthcare Conference

May 18, 2016

LAVAL, Quebec, May 18, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSX:VRX) today announced that Mr. Joseph Papa, Chairman and Chief Executive Officer, will participate at the UBS Global Healthcare Conference to be held at the Grand Hyatt Hotel in New York City on Monday, May 23, 2016 at 8:30 a.m. ET.

A live webcast and audio archive of the event will be available on Valeant's corporate website on the "Investor Relations" page, under the "Events and Presentations" tab and via this URL:

Participants are encouraged to allow approximately five to ten minutes prior to the start time to visit the site and download any streaming media software needed to listen to the event.

About Valeant  

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at

Contact Information:

Laurie W. Little                                             

Elif McDonald

Renée Soto
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.

Valeant Pharmaceuticals International, Inc.

Logo -


To view the original version on PR Newswire, visit:

SOURCE Valeant Pharmaceuticals International, Inc.